The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Bristol-Myers Squibb/Celgene; Gilead Sciences; Janssen Oncology; Roche; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Janssen
First results from the RedirecTT-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting BCMA and GPRC5D in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
 
Yael C Cohen
Honoraria - Amgen; GlaxoSmithKline; Janssen; Medison; Medison; NeoPharm; Takeda
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen; Medison
Research Funding - Amgen (Inst); Karyopharm Therapeutics (Inst); Takeda (Inst)
 
Daniel Morillo
Honoraria - Abbvie; Takeda
Travel, Accommodations, Expenses - Janssen Oncology
 
Moshe E Gatt
No Relationships to Disclose
 
Michael Sebag
Consulting or Advisory Role - BMSi; focus therapeutics; Gilead Sciences; Janssen; Janssen; Pfizer
Patents, Royalties, Other Intellectual Property - Patent but with no associated royalties or profit
 
Kihyun Kim
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; LG Chem; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Janssen
 
Chang-Ki Min
No Relationships to Disclose
 
Albert Oriol
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Enrique M Ocio
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Oncopeptides; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Oncopeptides; Pfizer; Sanofi; Takeda
Speakers' Bureau - Janssen-Cilag
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; Janssen
 
Sung-Soo Yoon
Honoraria - Novartis
Consulting or Advisory Role - Amgen; Celgene/Jazz; Janssen; Takeda
Research Funding - Kyowa Kirin; Roche/Genentech; Yuhan
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Michael Chu
No Relationships to Disclose
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Celgene; GlaxoSmithKline; H3 Biomedicine; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Janssen; Sanofi
Travel, Accommodations, Expenses - Pfizer
 
Irit Avivi
Consulting or Advisory Role - Novartis
 
Yue Guo
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Maria Krevvata
Employment - Janssen Research & Development
 
Michelle R. Peterson
No Relationships to Disclose
 
Melissa Jo Beelen
No Relationships to Disclose
 
Jill Vanak
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Arnob Banerjee
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Hila Magen
No Relationships to Disclose